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ABSTRACT A survey is presented of the carbohydrate of intercellular spaces
that is known to exist in the form of polysaccharide. This amounts to consider-
ing the polysaccharides made by connective tissue cells. The chemical structures
of these polysaccharides are discussed in the cases in which they are known and
regularities in patterns are noted. Such regularities make of these polysaccharides
a natural group that may be related to the natural group of connective tissue
cells that produce them. Viscosity is discussed as an important property of
hyaluronate. The polyelectrolyte properties of these polysaccharides are con-
sidered in detail mainly from the point of view of their use in studying the
polysaccharides, fractionating them, and accounting for their behavior in tissues.
Polyelectrolyte properties are considered in connection with simple cations,
micellar detergent cations, metachromatic dye cations, and protein cations. The
existence of the polysaccharides in native tissues as compounds with proteins is
discussed in detail, and with particular reference to the two cases most
thoroughly studied, the chondroitin sulfate of cartilage and the hyaluronate of
synovial fluid. A sharp distinction is drawn between compact and diffuse
macromolecules by a contrast of tropocollagen and hyaluronate. The known
proteinpolysaccharides of intercellular space are diffuse molecules. Experiments
are described to show how hyaluronate hinders sedimentation, excludes com-
pact macromolecules, or entangles with fibrils. Binding of water by connective
tissue and elasticity of cartilage may be related to the tissue content of such
diffuse macromolecules.
The foregoing discussions have been concerned with collagen, the protein that forms
water-insoluble fibers whose main function seems to be to create the mechanical
structure which is the gross outwardly recognizable animal body together with all its
internal pockets and furnishings. Distributed throughout this structure, the cells of
the animal live and carry out their biochemical processes. Their raw materials and
their metabolic products are carried to and from them by flow or diffusion in solu-
tion. They live in an aqueous environment, somewhat similar to plasma, but con-
taminmg, in addition to plasma components, another group of intercellular macro-
molecules which are generally water-soluble and which can be distinguished by the
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fact that they contain carbohydrate. The carbohydrate may consist of small units
attached to a large protein molecule, or the carbohydrate may itself be a macromole-
cule in which case it is called a polysaccharide. Macromolecules of polysaccharides
may also be attached to macromolecules of protein. Intercellular macromolecules
that contain carbohydrate are formed by cells of both epithelial and connective tis-
sues. Because of the mucilaginous nature and feel of the secretions of many epithelial
tissues the products they elaborate came to be called mucins and from this root there
grew a whole family of words such as mucoids, mucopolysaccharides, mucoproteins,
and mucinases. Because of the indiscriminate usage of many of these words in areas
in which characterization of the substances referred to has been extremely difficult,
these words have come to have ill-defined meanings and it may be best not to use
them.
The present discussion will be focused on those intercellular macromolecules in
which the carbohydrate is known to be in the form of a polysaccharide. This ex-
cludes many of the products derived from epithellal cells since in most cases we have
no knowledge of the size of the saccharide chains in these products, though in some
cases, as in submaxillary mucoid, the carbohydrate seems to be present as a large
number of oligosaccharide units separately attached to protein. In our present state
of ignorance this restricts our attention to the polysaccharides produced by cells of
the connective tissue. There are tissues of the body that are almost entirely composed
of connective tissue such as tendons, cartilage, and the derma of the skin. Many
other tissues, such as vessel walls or intestinal walls, are more or less intimate as-
sociations of connective tissue with other kinds of tissue. Since connective tissues
and their cells exist so widely spread throughout the body, so do the products of
their metabolism. Among these products are the polysaccharides which are our
present concern.
THE POLYSACCHARIDES
A polysaccharide is a macromolecule made up of many saccharide units. These units
may be all alike or they may be different. But even when different there are usually
only a few different kinds in any one polysaccharide, and they seem not to have the
apparently random distribution of the amino acid units in proteins. The known
polysaccharides of connective tissue have molecular weights that lie between 15,000
and 10,000,000, and the number of saccharide units in a molecule lies between 50
and 50,000. The most common saccharide unit in the world is glucose, and the
most common polysaccharide in the world is cellulose which is made up entirely of
glucose units in unbranched chains. The polysaccharides of connective tissue are
made up of saccharide units different from glucose but closely related to it and
metabolically easily derived from it. These saccharide units and their relation to
glucose are shown in the structures:
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In a polysaccharide, the saccharide units are united by the formation of an ether link
between the OH on C1 of one saccharide unit and an OH on a carbon atom other
than C1 of a second saccharide unit. As an example there is shown a short segment
of a starch molecule in which adjacent glucose molecules are linked by ether bonds
from C1 to C4.
It should be noticed that at C1 there are generally two ether bonds, one within a
single glucose unit, the other to the adjacent glucose unit. Where such double ether
links occur at a single carbon atom they have special properties and so they have a
special name; they are easily hydrolyzed by acids and they are called acetals. Also
shown are segments of the best known of the connective tissue polysaccharides,
sodium hyaluronate and sodium chondroitin sulfate. They are composed of a regular
alternation of two different saccharide units, and there is also a regular alternation of
C1 to C4 and C1 to Cs links as shown. Because of the regularity of these alternations
both the hyaluronate molecule and the chondroitin sulfate molecule can be considered
as long chains of similar disaccharide units, called repeating units or periods. The
determination of the structural details of this and of most of the other polysaccharides
of connective tissue is very largely due to the painstaking work of Karl Meyer (1-3).
The other polysaccharides of connective tissue whose structures are known at least
partly are listed in Table I. This shows the component saccharide units and the
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Starch segment
Sodium hyaluronate segment
*COCH3NH- COCH3 OH
Sodium chondroitin sulfate segment
occurrence of ester sulfate or amide sulfate as an additional repeating component.
Without going into details of the structure of each polysaccharide certain generaliza-
tions seem true of all of them. Each polysaccharide is composed of two different
saccharide units which alternate regularly along a chain in which so far no branching
has been proved to occur. In all cases one of the saccharide units is a hexosamiine,
TABLE I
THE COMPONENTS OF SOME INTERCELLULAR POLYSACCHARIDES
PRODUCED BY CONNECTIVE TISSUE CELLS
Sulfates/Period
Polysaccharide Hexosamine Hexuronate Hexose Ester Amide
Hyaluronate Glucosamine Glucuronate
Chondroitin-4-sulfate Galactosamine Glucuronate - 1.0
Chondroitin-6-sulfate Galactosamine Glucuronate 1.0
Dermatan-4sulfate Galactosamine Iduronate 1.0
Heparin Glucosamine Glucuronate 1.5 1.0
Heparitin sulfate Glucosamine Glucuronate 0.5 0.5
Keratan sulfate Glucosamine - Galactose 1.0
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either D-glucosamine of D-galactosamine. The other saccharide unit in most cases is
a uronic acid, either D-glucuronic or L-iduronic acid, but in one case is D-galactose.
The amino group of the hexosamine seems never to be free; it is either acetylated or
it is sulfated. The result of this is that it is never basic, and at the pH of tissues
these amide groups do not attach a proton and cannot become positively charged
or cationic. On the other hand each of these polysaccharides has anionic groups;
carboxylate, ester sulfate, or amide sulfate, which at the pH of tissues, exist as a
negatively charged or anionic group, each associated with a small cation such as
sodium. This may be their most important characteristic. Each molecule of any one
of these connective tissue polysaccharides carries a large number of negative charges
attached to and regularly spaced along the polysaccharide chain. To this we will
return later.
These polysaccharides form a natural group for several reasons; they seem to have
a set of structural similarities in common, they all seem to be produced by connective
tissue cells of one kind or another, and they all are regularly repeating polyanions.
But there are different kinds of connective tissue and they contain cells with dif-
ferent patterns of polysaccharide production. These different kinds of connective
tissue cells are all thought to be derived from a single kind of ancestral cell called
the primitive mesenchymal cell which is itself derived from the mesoderm of the
embryo. In further development the primitive mesenchymal cell seems to be able to
change to one of a number of specialized forms only a few of which have specialized
names as indicated in Table II. Perhaps the least specialized is the fibroblast, but this
TABLE II
SOME PRODUC1S FORMED BY A FEW TYPES
OF CONNECTIVE TISSUE CELLS
Mesoderm
4 1
Muscle Undifferentiated mesenchymal cell
Synovial Mast
Fibroblast living cell cell Chondroblast Osteoblast
Collagen + - - + +
Hyaluronate + + - - -
Chondroitin sulfate + - - + +
Heparin - - +
may only be because we have not yet learned to distinguish different kinds of fibro-
blasts, for certainly in different areas of the body cells called fibroblasts produce
different kinds of tissue. Tendon and derma are obviously and chemically different
tissues yet the cells that produce them are both called fibroblasts. We do not at
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present know in enough detail the kinds and proportions of polysaccharides that are
produced by each kind of connective tissue cell. Table II gives only a gross sum-
mary which shows that there are indeed great differences in the products produced.
Besides the different polysaccharides produced by connective tissue cells in mam-
mals listed in Table II there are others related to these but less well defined. There
is for instance one found in corneal tissue that seems to be similar to chondroitin
sulfate but that contains very little sulfate and so is called chondroitin (4). The
study of connective tissues in animals other than mammals promises to open up a
vast area for the study of the evolution of connective tissue polysaccharides as related
to the evolution of the animal forms that carry them. At present only a few such
forms have been studied. In shark, horseshoe crab, and squid there were found
forms of chondroitin-6-sulfate and keratan sulfate that contain between one and two
ester sulfates per period (5, 6). A marine snail has a tissue resembling cartilage that
was found to contain a very different, yet still related polysaccharide, a polyglucose
sulfate (7).
Of these polysaccharides the two most thoroughly studied are hyaluronate and
chondroitin sulfate. The structure of hyaluronate shows the regular alternation of
glucosamine and glucuronate links, and the alternation of 1 -> 3 and 1 -+ 4 links.
These links are of very unequal stabiity with respect to acid hydrolysis, the
glucosaminidic link is split much more readily than the glucuronidic link
with the result that rather good yields of the disaccharide, hyalobiuronic acid, can
be obtained after mild acid hydrolysis.
There are several enzymes called hyaluronidases capable of hydrolyzing hyalu-
ronate. A second area of Karl Meyer's achievements lies in working out some of the
details of the action of hyaluronidases from different sources (8). The action of the
first, found in mammalian testicular tissue and in snake venom, is to split the hexo-
samnirdic bond, and to yield as the main product a tetrasaccharide having the
glucosamine at the reducing end of the molecule. The action of the second, found
in the head of the medicinal leech, is to split the hexuronidic link, and to yield as the
main product a tetrasaccharide having the glucuronate at the reducing end of the
molecule. The action of the third, found in bacterial extracts, is radically different in
character. It splits the hyaluronate at the hexosaminidic link but the final product
is a disaccharide of a new kind, having a double bond between C4 and C5 of the
hexuronate ring. This disaccharide has the unusual property of absorbing ultraviolet
light at 230 m,&. The only clear evidence for the existence of hyaluronidase in mam-
malian tissues is that for testicular tissue.
The molecular weight of hyaluronate depends on its source (9), that from vitreous
humor is of the order of 200,000 to 500,000 but that from synovial fluid, umbilical
cord, or rooster comb lies in the range 1 to 5 x 10g. Hyaluronate of molecular
weight 106 would have 2500 periods. Since there is no evidence of branching, the
length of the chain would be about 25,000 A or 2.5 ja. Stretched out, its length would
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be one-third the diameter of a red cell. In the absence of constraints to hold it in
this position a molecule in solution could not remain completely stretched out. Such
a configuration is quite improbable. In very dilute solution the size, or rather the
space, through which such a molecule extends has been estimated to be 4000 A,
and light-scattering results have been interpreted to indicate a spherical shape. A
molecule of molecular weight 106 in solution in a spherical volume of 4000 A diame-
ter would correspond to a solution concentration of about 0.01 per cent.
One of the most interesting properties of hyaluronate is the high viscosity of its
aqueous solutions. This is such a prominent property that it has been thought to be
related to its functions in tissues. Its occurrence in the synovial fluid of joints has
suggested that it has a lubricating function. In other tissues such as derma it might
have a lubricating function at a molecular level, perhaps acting as a plasticizer to
diminish friction and wear between collagen fibrils. Another function has been
thought to be as a retardant to invasion of tissues by bacteria. In this connection it
has been thought that bacteria which produce their own hyaluronidase would thereby
have an advantage in invading tissues.
Viscosity is a measure of the drag or friction exerted by adjacent layers of fluid
that are moving past each other. In a solution this depends on the sizes and shapes
of both solvent and solute molecules. The unusually high viscosity of hyaluronate
solutions is related to the unusually large volume or domain these molecules occupy
in solution. What is the condition in a very dilute solution, of a molecule that spreads
throughout so large a volume of space that it is equivalent to a 0.01 per cent solu-
tion? It is not a compact molecule but a highly diffuse, spreading molecule. There is
no evidence of any significant or stable cross-linking of the long hyaluronate chain.
It seems to exist in solution as a very loosely coiled, somewhat stiff, randomly dis-
tributed, unbranched chain. The hyaluronate molecule does not occupy all the space,
the domain, through which it is spread. Molecules of water and small solute mole-
cules can drift freely through this domain. In solutions of hyaluronate below 0.01
per cent the molecular domains will tend to form separate islands. In human synovial
fluid the concentration of hyaluronate is about 0.4 per cent. In such a solution as a
whole hyaluronate is more concentrated than it is in the domain occupied by each
hyaluronate molecule in a very dilute solution. When the molecules become so
crowded together they may occupy much smaller domains, or they may interpene-
trate. When adjacent layers of such a solution move relatively to each other, there
could be expected to be a drag on the partially flexible hyaluronate chains by the
flow of water past them, a drag of adjacent diffuse hyaluronate molecules against
each other, deforming each other, and a drag of adjacent molecules that may have
interpenetrated so that their chains have become to some extent entangled.
Hyaluronate is the only one of the connective tissue polysaccharides whose solu-
tions have such a pronounced viscosity. The others have by comparison only
negligible viscosities. The others also have, as polysaccharides, much lower molec-
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ular weights and could not extend throughout so large a domain in solution. The
high viscosity of hyaluronate solutions makes it easy to observe hydrolytic effects
more subtle than can be detected by chemical means. For example the very earliest
stages of hyaluronidase action may produce striking changes in viscosity when so
few glycosidic bonds are broken that they are scarcely detectable by chemical
measure of the increased number of reducing end groups present. This may account
for the observations of Pigman (10) that hyaluronate solutions in the presence of
cysteine, hydroquinone, or ferrous salts may show marked loss of viscosity.
POLYELECTROLYTE PROPERTIES
All the polysaccharides of the group under discussion have one property in common
that is probably of importance in their functioning in the tissue and is certainly of
importance in studying their behavior in solution and in separating them from other
connective tissue components and from each other; they all carry a large number of
negatively charged groups. There is at least one and sometimes more than two for
each repeating disaccharide unit, so the charges are rather evenly distributed along
the chains, but their distribution along chains may not always be strictly regular.
These polysaccharides are therefore also polyanionic and are always associated with
an equivalent number of cations, called counterions. In tissues the most common
cations of extracellular spaces are sodium ions so that the polysaccharides occur in
tissues almost entirely as sodium salts. However, other cations can readily be ex-
changed and the extent to which this occurs is determined mainly by their concentra-
tion in solution and their valence. In tissues potassium, calcium, and magnesium ions
will also be associated with the polysaccharides though in amounts much smaller
than sodium. These polyanionic polysaccharides behave as weak electrolytes; they
behave as if a considerable fraction of the cations were not altogether free. Cations
can all be freely exchanged by other cations in the solution, but they are not alto-
gether freely mobile, a fraction behaves as if bound by the polyanion. This fraction
in the case of chondroitin sulfate has been shown to amount to about 50 per cent of
the counterions associated with chondroitin sulfate when the counterions are sodium
or potassium, or 70 per cent of the counterions when these are calcium (11, 12).
Counterions of higher valence are bound to an even higher degree. The trivalent
cation containing cobalt associated with six neutral ammonia molecules, precipitates
chondroitin sulfate and heparin directly from dilute aqueous solution, and the hexa-
valent cobalt cation of hexol chloride even precipitates hyaluronate directly from
very dilute aqueous solution (13, 14). An important aspect of this binding of simple
cations of higher valence is that even these more firmly bound polyvalent cations can
be displaced from the polyanionic chain by univalent cations provided there are
enough of the univalent cations in the neighborhood; that is if their concentration is
sufficiently high. A practical result of this is that a precipitate of the trivalent hexam-
minecobaltic cation with chondroitin sulfate can easily be redissolved by addition of
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sodium chloride to a concentration of 0.05 M. This binding or fixing of simple poly-
valent cations is used in histochemical studies to locate in tissue sections the positions
of polyanionic polysaccharides. In the Hale stain a trivalent ferric cation complex
with manitol is used, and the locations where it has been fixed are then made visible
by the addition of ferrocyanide producing a precipitate of Prussian blue at these
sites. More recently a dye, Alcian blue, has come into use for the same purpose. This
is a dye with a tetravalent cation that directly stainls areas containing polyanionic
polysaccharides. The finding of hyaluronate in the electric organ of the electric eel
has raised a question whether the effect of curare on this organ might be related in
some way to the observed binding of divalent curare cations to hyaluronate poly-
anions (15).
Another area in which the polyanionic properties of connective tissue polysac-
charides are of use lies in their behavior with cationic detergents. The ionic detergents
or soaps are generally molecules with a long hydrocarbon chain having at one end a
fixed ionic group. The hydrocarbon chain of the molecule is hydrophobic or
lipophilic, like paraffin; the ionic part is hydrophilic. Such molecules act as if they
had a dual personality, they might be called schizophilic. In water such molecules
tend to collect at surfaces with their hydrophobic parts being almost literally pushed
out of the water. Deep in the water such molecules tend to associate with each other
and form aggregates with their hydrophobic parts pressed together offering least
total exposure to the water. Such aggregates are called micelles. Since one end of
each molecule carries a fixed charge, the micelle as a whole carries a large number
of fixed charges, perhaps 50 to 100. A cationic detergent, such as cetyl pyridinium
chloride, in solution in water forms micelles that act as polyvalent cations with a
high charge. As might be expected from what has been said of simple polyvalent
cations, such cationic micelles associate with polyanionic polysaccharides and pre-
cipitate them from solution. As might also be expected, such precipitates can gen-
erally be redissolved by the addition of neutral salts such as sodium chloride. The
salt concentration required just to prevent such precipitation, or to redissolve pre-
cipitates already formed, is different for different anionic polysaccharides. This set
of properties forms the basis for a method of fractionating anionic polysaccharides
which in practice can be carried out in different ways (16-18).
Still another area in which use is made of the polyanionic properties of connective
tissue polysaccharides lies in the histochemical application of metachromatic stain-
ing. In this peculiar type of staining a violet to red color results in those parts of
tissue sections that contain anionic polysaccharides when they are stained with a
blue solution of toluidine blue. The spectral changes that occur in dilute solutions of
toluidine blue or in solutions of other metachromatic dyes on addition of chondroitin
sulfate or hyaluronate have been extensively studied (19, 20). The essentials needed
to produce the metachromatic color are: a cationic dye that does not obey Beer's
law, that is to say, a dye whose spectrum changes with concentration; a polyanion
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in solution; and a low salt concentration, all in aqueous solution. There is now evi-
dence that the metachromatic color is due to the formation in solution of a single
compound composed of equivalent amounts of appropriate cationic dye and poly-
anion. Such compounds can be rather specifically removed from solution by high
speed centrifugation, by adsorption to CaHPO4, or by shaking their solutions with
an immiscible organic solvent (21). In the last case the metachromatic compound
collects at the interface and does not at all enter the organic solvent. Analysis of the
products removed in all these cases showed them to contain dye and polyanion in
equivalent amounts even when the polyanion present in the original solution was in
a tenfold excess over the dye. The spectral changes that occur on the addition of a
salt of a polyanion to a solution containing the dye cation have been interpreted as
due to the formation of a single salt-like compound of dye and polyanion stabilized
by the sharing of 7r-electrons between adjacent dye molecules fixed at regular in-
tervals along the polyanionic chain. The sharing of 7r-electrons between adjacent dye
molecules is presumably the cause of the color change of the dye associated with the
polyanion. The stability of metachromatic compounds varies widely for different
combinations of dye and polyanion, and depends not only on the r-electron bonds
but also on the electrostatic bonds. A method has been described to measure rela-
tive stabilities of different metachromatic compounds in terms of the ethanol con-
centration at which the main band (a-band) of the free dye has returned half-way
to its value when the dye is alone in ethanol (22).
Another kind of electrostatic interaction with connective tissue polysaccharides,
that may be of physiological importance and that has also been found of use in
laboratory studies, is that with proteins. This takes its simplest form under condi-
tions such that the protein is dominantly cationic. An example is the mucin clot
formed in synovial fluid on the addition of acetic acid. In the acid medium the serum
albumin, which is the protein present in largest amount in normal synovial fluid, be-
comes cationic and precipitates with the anionic hyaluronate. Progressive digestion
of hyaluronate by hyaluronidase can be followed by progressive loss of the turbidity
produced by the addition of serum and acetic acid to samples taken from the reaction
mixture. Interaction between proteins and anionic polysaccharides is, however, not
confined to immediate precipitation. Fig. 1 shows some results of a study (23) of
the interaction between chondroitin sulfate and lysozyme, a protein of molecular
weight about 16,000 and having a net positive charge of about 8 at pH 7. As long as
lysozyme is in excess and salt concentration is low (<0.06 M KCI) the amount of
lysozyme removed from solution is exactly proportional to the amount of chondroitin
sulfate added. At exact equivalence there is practically no lysozyme left in solution
and up to this point the product, apparently a simple salt of lysozyme and chondroitin
sulfate containing equivalent amounts of each, can be centrifuged off completely at
low centrifugal speed. In the absence of salt a small excess of chondroitin sulfate
causes abrupt and striking changes. The product can be only partly centrifuged off
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at low speed leaving an opalescent solution. Centrifuged at higher speed, over
30,000 RPM, a clear supernatant solution results but contains 25 to 60 per cent of the
initial lysozyme as the chondroitin sulfate equivalence is raised from 1.5 to 6.0. At
a low salt concentration (0.03 to 0.06 M KCI) the situation again changes and
even in the presence of excess chondroitin sulfate up to fivefold nearly but not quite
all of the lysozyme can be removed. A further set of changes occurs at progressively
higher salt concentrations up to the physiological range; progressively less lysozyme
is removed from solution, and this occurs in either lysozyme or chondroitin sulfate
excess. Analysis of the products removed from solution in the presence of 0.15 M
KCI by this centrifugal procedure shows that in the presence of progressively greater
excess of chondroitin sulfate the products contain progressively more chondroitin
sulfate for each equivalent of lysozyme. In other words, not all the anionic groups
of chondroitin sulfate are associated with an equivalent of lysozyme cation. Some-
what parallel findings have been reported for several other proteins, particularly
serum globulins, but the results cannot be so clearly analyzed in terms of equivalents
because the effective cationic charge per mol of a mixture of globuilins cannot be so
sharply calculated (24).
Considerable emphasis has been put on discussion of the polyelectrolyte properties
of connective tissue polysaccharides because these are among their most outstanding
characteristics. These properties are not only of value in the development of labora-
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tory methods to fractionate and to study them, but also are probably fundamental
to their functions in the extracellular spaces of the living organism.
COMPOUNDS OF PROTEIN AND POLYSACCHARIDE
Krukenberg (25) in 1884 was the first to isolate one of the polysaccharides of this
group. By extraction of cartilage with 5 to 10 per cent sodium hydroxide for 2 to 3
days he isolated in a recognizable form what we now call chondroitin-4-sulfate. He
actually called it chondroitic acid reviving an earlier name bestowed by Boedeker
before 1861. Boedeker used this name for a component of cartilage which he had
never isolated but which he recognized as being carbohydrate in nature. Krukenberg
clearly stated that, since water alone extracted only traces of chondroitin sulfate, and
the much more drastic treatment with sodium hydroxide was necessary for its separa-
tion, the chondroitin sulfate could not exist as such in the native cartilage. A few
years later in 1891 Schmiedeberg (26) came to the conclusion that the chondroitin
sulfate of cartilage existed in the native state as compounds with proteins. The
products then known all contained 12 to 15 per cent nitrogen or 75 to 90 per cent
protein, much of which was gelatin formed from the collagen of cartilage during the
rather drastic extraction procedure. More recently it has been found possible to
isolate from cartilage about 80 per cent of its total content of chondroitin sulfate by
extraction with water or dilute solutions of neutral salts provided the tissue structure
is mechanically disintegrated sufficiently. The product isolated by such procedures
behaved as a compound of chondroitin sulfate and protein. For instance, attempts
to fractionate it by graded precipitation of its salts with alcohol were unsuccessful,
protein could not be selectively removed by the use of protein adsorbants, and
electrophoretically it migrated as a single component, with a mobility that was con-
stant over the range of pH from 5 to 10 and practically equal to the mobility of
chondroitin sulfate. This product was called chondromucoprotein (27). In a later
study (28) of its centrifugal properties it was found possible to separate it into two
distinct fractions, one of which sedimented readily at 50,000 X g, and the second
of which did not sediment readily at 100,000 x g. Both products consisted mainly
of chondroitin sulfate and protein. From bovine nasal cartilage the less easily sedi-
mentable fraction constituted about 80 per cent of the total chondromucoprotein
isolated from cartilage, and it consisted of about 85 per cent chondroitin sulfate and
15 per cent protein. About this time there were being raised rather valid objections
against the use of the words mucopolysaccharides and mucoproteins, so these pro-
ducts were referred to as proteinpolysaccharides (in analogy with lipoprotein and
lipopolysaccharide). This emphasized the fact that these compounds contained
carbohydrate in the form of a polysaccharide, as distinct from glycoproteins, in many
of which the carbohydrate appears to exist as oligosaccharides. So the new products
were called PP-H and PP-L, heavy and light referring to their ease of sedimentability.
A more specific name than proteinpolysaccharide could be proteinchondroitin-4-
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sulfate. Molecular weight estimation on products made by similar methods by
Mathews and Lozaityte (29) gave values in the range 4 X 106 to 50 x 106. Sedi-
mentation and zone electrophoresis study of PP-L showed that it behaved as a single
entity. Similar studies could not be made with PP-H because of its easy sedimenta-
bility and its immobility in zone electrophoresis. Both products on treatment with
sodium hydroxide (0.15 N, 16 hours, 250) yielded chondroitin-4-sulfate in the
amounts expected. This chondroitin sulfate persistently contained about 5 per cent
protein. Further analysis in several laboratories showed that both PP-L and PP-H
contained small amounts of glucosamine and galactose (30) as well as sialic acid
(31). Among the alkaline hydrolysis products of both PP-L and PP-H small amounts
of keratan sulfate have been found. It is with the keratan sulfate that the sialic acid
seems to be associated. PP-L can be degraded to give chondroitin sulfate not only
by alkali but by trypsin. The chondroitin sulfate produced by trypsin degradation is
similar to that produced by alkaline degradation but differs in one important respect,
its chain weight is higher. Chain weight is a valuable tool developed by Partridge,
Davis, and Adair (32) to measure the number of reducing end groups per gram of
material. Since each polysaccharide chain has only one reducing end group per chain,
the larger the number of end groups per gram the shorter the chain length. Chon-
droitin sulfate made by alkaline digestion has a chain length about half that made by
trypsin digestion. Furthermore that made by trypsin digestion is about the same as
that found in PP-L itself. In other words, PP-L consists of protein and a number
(about 15 to 20) of independent chains of chondroitin sulfate, each with its own re,
ducing end group, for a molecular weight of 10g. PP-L is a highly branched molecule.
Human cartilage, both articular and costal, differs in several respects from bovine
nasal cartilage. It contains less total polysaccharide, it contains a larger fraction of
PP-H and a smaller fraction of PP-L, and both PP-H and PP-L contain a larger
fraction of keratan sulfate and a smaller fraction of chondroitin sulfate. A further
difference is that while PP-L from bovine nasal cartilage behaves in free electro-
phoresis as a single entity, PP-L from human costal cartilage shows two distinct
peaks.
These compounds of protein and chondroitin sulfate seem to be catabolized (33)
and synthesized (34) as a unit.
Work on connective tissues other than cartilage, aimed at showing the existence of
compounds of protein and the amionic polysaccharides, involves several additional
complications. Most other connective tissues contain much smaller percentages of
total polysaccharides, there are frequently at least three or four different polysac-
charides present, and finally the tissues are more commonly interpenetrated by other
more or less unrelated tissues and are richer in content of cells. Examples of such
kinds of connective tissue are derma, tendons, heart valves, and arterial vessels. In
aorta there is evidence for the presence of at least four polysaccharides; hyaluronate,
chondroitin-6-sulfate, dermatan-4-sulfate, and heparitin sulfate. Extraction of hu-
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man aorta with water during appropriate disintegration of the whole tissue, followed
by high speed centrifugal fractionation, and purification of the not readily sedimenta-
ble material on a cellulose column by the use of a cetylpyridinium salt by the princi-
ples discussed earlier led to the isolation of a compound of protein and chondroitin-
6-sulfate apparently of the same general composition and properties as the PP-L
from bovine nasal cartilage (35).
There have been a few reports of mild experimental procedures for extraction of
connective tissues, particularly of cartilage, in which the claim has been made that
a polysaccharide free of protein could be isolated. In the cases of those methods
which have been rechecked no free polysaccharide has been found. While it is not
possible to say at present that all connective tissue polysaccharides occur in the
native state bound to protein, there is no clear case in which a polysaccharide free
of protein is known to occur. There is a thought, however, which suggests that there
might be small amounts of polysaccharide relatively free of protein in connective
tissue. Where measurements have been made it seems that the half-life of these
polysaccharides in the tissues is of the order of a week. It is possible that in their
normal turnover the first step could be breakdown of the native protein polysac-
charide compounds releasing polysaccharides relatively free of protein as mentioned
above in the action of trypsin on PP-L. Such small fragments could diffuse out of the
tissue rapidly.
A case of special interest is hyaluronate. From vitreous humor it has been isolated
in a form thought to be free of protein (36) yet the data presented indicate a protein
content of 2 per cent. From synovial fluid the material isolable has been the subject
of considerable controversy. The mucin clot produced by acidification of diluted
synovial fluid with acetic acid is mainly a salt of cationic albumin and anionic
hyaluronate. A major advance in the purification of synovial fluid hyaluronate was
made when it was found (37) that hyaluronate molecules in solution could literally
be filtered out of the solution by passage through fine fritted glass filters having an
average pore diameter of about 600 mnf. A large fraction of the albumin and globulin
content of synovial fluid easily passes through such filters while all the hyaluronate is
retained. This is another consequence of the large domain occupied in solution by
the hyaluronate molecule, discussed in connection with the viscosity of hyaluronate
solutions. Washing of the hyaluronate retained by stirring with dilute salt solutions
and continuing the filtration was repeated up to 20 and even 30 times during a total
time of over a month. The product left in solution on the filter was considered to be
a compound of hyaluronate and protein containing about 25 per cent protein. In
more recent work (38) millipore filters with a pore diameter of 100 mp have been
used instead of the glass filters, and the retained hyaluronate dissolved in dilute salt
solution passed through a column packed with a mixture of IRC-50 and hydroxyl-
apatite. The procedure is far more rapid and yields a product with a much lower
protein content, about 2 per cent. That this protein was bound to the hyaluronate
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was shown in several ways. Perhaps the most convincing was to label it with iodine-
131 and show that on zone electrophoresis at several pH values the uronic acid and
I131 traveled together.
It seems to be true that hyaluronate and all the sulfated connective tissue poly-
saccharides in their native state in tissues are bound to protein. In two cases which
have been studied in some detail, hyaluronate and chondroitin sulfate, there is
evidence of a marked difference in the structure of these compounds of protein and
polysaccharide. In the case of hyaluronate the polysaccharide itself appears to be a
single long unbranched chain with a molecular weight about 106. The protein chain
to which it is attached, about 2 per cent of the whole molecule, could not have a
weight over 20,000. The properties of the polysaccharide dominate the properties
of the proteinpolysaccharide, and nibbling at the protein with a protease has no
observable effect on the domain occupied by the molecule as expressed in its viscosity
properties. The relation between protein and polysaccharide in the native form of
chondroitin sulfate is quite different. In the first place, there seem to be at least two
forms of association of chondroitin sulfate with protein, those called PP-H and PP-L.
Of these PP-H cannot yet be purified sufficiently to be able to characterize it as a
single molecular entity. It is even difficult, because it can be so easily sedimented
from its very opalescent solution, to make an intelligible statement about its solu-
bility. In this respect PP-L is far more tractable, gives solutions clear enough so
that optical rotation can be determined, sediments as a single entity, and no attempts
at fractionation have yet given clearly separable components. PP-L is similar to
synovial fluid hyaluronate in having a molecular weight about 108, but it contains
15 per cent protein. In this molecule the chondroitin sulfate is not a single con-
tinuous polysaccharide chain as is the case in the hyaluronate compound with pro-
tein. Reducing end group assay combined with molecular weight determination
indicates that in a molecule of PP-L of molecular weight 108 there are about 17
chondroitin sulfate chains with an average weight of 50,000 each. Filtration ex-
periments similar to those described for hyaluronate, as well as viscosity measure-
ments, also indicate that PP-L occupies a large domain, though not so large as
hyaluronate. This would be expected since at least 17 constraints have been imposed
on the spreading of the PP-L molecule to a large domain in solution by the separate
binding of each chondroitin sulfate chain. The PP-L molecule is a relatively highly
branched molecule compared to hyaluronate. This difference is strikingly reflected
in the contrast of the effects of trypsin. On hyaluronate with its single long poly-
saccharide chain and its 2 per cent protein, trypsin has no effect on the viscosity of
the solution nor on the domain of the molecule. On PP-L with its multiple shorter
polysaccharide chains and its 15 per cent protein, trypsin produces a sudden and
large drop in viscosity, the domain occupied by the PP-L has collapsed, the separate
chondroitin sulfate chains occupy rather small domains and become easily filterable
through millipore filters of 100 mjA pore size.
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The nature of the binding of the chondroitin sulfate chains to protein in PP-L has
been a subject of speculation since before PP-L was known because it was generally
assumed that in native cartilage the chondroitin sulfate must be attached to some
protein. The ease with which chondroitin sulfate can be extracted from cartilage by
the use of dilute alkali naturally led to the suggestion of an ester bond. Treatment of
PP-L with hydroxylamine at pH 9-10 has yielded no product characterizable as
chondroitin sulfate.
PROTEINPOLYSACCHARIDES AS DIFFUSE MOLECULES
The polysaccharides of connective tissues exist mainly in that space between cells
and fibers called ground substance. In this area the known forms seem to exist in
solution as compounds with protein. Though they are generally water-soluble there
are also some forms, as PP-H, whose condition as regards solubility in water when
isolated from the more soluble proteinpolysaccharides, is not clear. Of the more
soluble forms, hyaluronate and PP-L have been discussed in particular. They have
some striling properties that may account for much of their physiological function.
Two of these properties considered in some detail are their properties as polyanions,
and their existence in solution not as compact molecules but as highly diffuse mole-
cules that extend throughout a volume of the solution, called their domain, that is
large in comparison to the weight of the molecule, such as 1 to 10 liters per gm.
Consider for example a comparison of the volumes of the space in solution oc-
cupied by equal weights of tropocollagen and hyaluronate. The hyaluronate mole-
cule, MW 106, occupies a sphere of diameter 4000 A or a volume of 330,000 x
10-19 ml. A molecule of soluble collagen, MW 345,000, occupies a rigid cylinder of
diameter 14 A and length 2800 A, or a volume of 4.3 x 10-19 ml. Three such col-
lagen molecules would weigh as much as a hyaluronate molecule, but the hyaluronate
molecule occupies 25,000 times as much space as the three collagen molecules. This
illustrates the difference between the diffuse hyaluronate and the compact collagen
molecules. The domain occupied by a diffuse molecule in solution may be likened
to the space occupied by a hedge, a piece of foam rubber, or a mass of sephadex gel
in a column. Such a domain has different degrees of porosity to molecules of dif-
ferent sizes and it offers different degrees of resistance to the passage of other
molecules througlh it, depending more on their size and shape than on the chemical
identity of their component atoms. Several kinds of experiments have been reported
in recent years on methods with which measurements can be made of these proper-
ties.
A study was made by Laurent and Pietruszkiewicz (39) of the effect of hyalu-
ronate in solution on the rate of sedimentation in a centrifugal field of a series of
particles varying in size from serum albumin, through virus particles, to polystyrene
latex particles. The results showed that only a small effect of hyaluronate was noticea-
ble in slowing up the sedimentation of serum albumin (40 x 150 A) but that the
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retarding effects on the sedimentation of larger particles increased very rapidly as
the sizes of the particles increased from 300 to 3000 A. Increasing hyaluronate con-
centration also decreased the sedimentation rates of all these particles but the de-
crease was always greater the larger the particle. These results were interpreted in
terms of a random three dimensional network of hyaluronate chains extended
throughout the solution acting as a brake to slow up the rate of fall of the particles,
and slowing them up more markedly the larger the particles and therefore the
greater the probability of their encountering chains across their paths. The effects
noted here are reminiscent of the interpretation of the action of spreading factors
noted years ago when testicular extract containing hyaluronidase was found to in-
crease the rate of spread of large colloidal particles through rabbit skin.
There is another kind of effect of hyaluronate in solution on large molecules that
is different from the one just described because it measures an effect on an equilibrium
condition and not on the rate of a process. This is described by Ogston and Phelps
(40) and appears to be a further outcome of the work of that laboratory on the use
of filters of small pore size. In this work the millipore ifiter was used as a diffusion
membrane, impermeable to hyaluronate but permeable to molecules of the size of
serum globulins or serum albumins. With such a system equilibrium dialysis experi-
ments were set up. Hyaluronate in buffer was dialyzed against inulin in buffer. When
the system came to equilibrium there was markedly less inulin in the solution on the
side of the membrane where there was hyaluronate than on the side where there was
no hyaluronate. The same effect resulted if at the start of the experiment the inulin
was put in the same solution as the hyaluronate. On equilibration less inulin stayed
on the side of the membrane with hyaluronate than on the side with no hyaluronate.
Similar results were found when a variety of other large molecules, all of which
were small enough to be able to diffuse through the millipore ifiter, were dialyzed
with hyaluronate on only one side of the membrane. These other molecules in-
cluded serum albumin, carbon monoxide hemoglobin, dinitrophenyl derivatives of
several proteins, and several forms of polyglucose. All these substances dialyzed
against hyaluronate showed the same effect at equilibrium. Their concentration on
the side of the membrane containing hyaluronate was less than their concentration
on the side containing no hyaluronate. On the other hand, small molecules came to
equilibrium with equal concentrations on the sides with and without hyaluronate.
The effect of the hyaluronate appeared to be to exclude large solutes from a part
of the solution it occupied. The fraction of the hyaluronate solution from which
large solutes appeared to be excluded could be called the excluded volume with
respect to a particular solute such as albumin. The apparent excluded volume be-
came larger the higher the concentration of hyaluronate, and the larger the mole-
cular size of the solute excluded.
In this case, as in the work on sedimentation, the concept of a random three
dimensional network of hyaluronate chains is used as the basis to explain the re-
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sults. Statistically these chains will often form regions of high chain densities into
which large molecules cannot penetrate, and chain stiffness does not allow rapid
adjustment of the chains to admit intruding large molecules. The volume actually
occupied by the hyaluronate chains may include a hydration zone of fixed water of
unknown size. This phenomenon suggests some interesting speculation concerning
the plasma protein content of normal and arthritic synovial fluid. Normal plasma
contains about 7 per cent protein, normal synovial fluid about 2 per cent protein.
This is, at least as regards order of magnitude, what one might expect in a millipore
dialysis system with a concentration of hyaluronate of 0.3 to 0.4 per cent on one side
and a concentration of total plasma protein at equilibrium of 7 per cent on the other
side. In arthritic fluid where the hyaluronate concentration is about half that in nor-
mal fluid, the amount of plasma protein could be expected approximately to double,
and in arthritics the protein content of the synovial fluid averages about 4 per cent.
Still another kind of effect of hyaluronate in solution has been studied. This came
from a consideration of how these molecules, which occupy such an extensive
domain, might interact with insoluble fibrils. This is an attempt to approach the real
conditions existing in native connective tissues where a fibrillar network of collagen
fibrils traverses areas of ground substance. A study of this type was made by Fessler
(41) using a rather simple procedure with interesting results. A solution of collagen
containing 2.5 mg per ml was made by extraction of tissues with cold sodium
chloride solution. On being heated to 370 it yielded a stiff gel of precipitated collagen
fibrils. When this gel was centrifuged it produced a small pellet of sedimented col-
lagen fibrils with water trapped between them. The net weight of such a pellet
amounted to 10 mg per mg of collagen taken in the initial solution of collagen. The
effect of dissolved hyaluronate on this system was then studied. Before precipitation
of the collagen fibrils, hyaluronate to the extent of 0.06 per cent was added to the
cold collagen solution, and the combined solution of collagen and hyaluronate was
heated to 370 as before. This again resulted in precipitation of the collagen fibrils
in the form of a gel. On centrifugation of this gel a pellet was again produced but
this time weighed five times as much as the control pellet formed in the absence of
hyaluronate. Of course, this increase in the pellet weight is due to the increased
amount of water trapped among the fibrils. A small extra amount of hyaluronate was
also trapped among the pellet fibrils as was shown by the decrease in concentration
of the hyaluronate of the supematant solution. The pellets formed in the absence and
in the presence of hyaluronate contain the same amount of collagen and the weight
of hyaluronate trapped in the experimental pellet is completely negligible. Why then
does the pellet formed from the very diulte hyaluronate solution weigh so much more
than the control pellet? Both were formed in a centrifugal field of the same magni-
tude. The fibrils formed in the hyaluronate solution resisted compression more than
those formed in the absence of hyaluronate. It is as if the fibrils sedimented in the
presence of hyaluronate had springs interposed between them opposing the force
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of the centrifugal field tending to compress them. This thought agreed with the
observation that the hyaluronate pellet differed markedly from the control pellet in
having a firm elastic consistency and that this elastic property was lost when the
pellet was incubated with hyaluronidase. Control pellets did not have this elastic
property and were unaffected by hyaluronidase.
The picture drawn from these experiments is that collagen fibrils formed in
hyaluronate solution penetrate through the domains of hyaluronate molecules, that
hyaluronate molecules not only become entangled with each other but with insoluble
collagen fibrils. The dimensions of collagen fibrils (about 500 A in diameter) and of
hyaluronate domains (4000 A in diameter) allow this possibility. Resistance of col-
lagen fibrils in hyaluronate solution to compression in a centrifugal field is then a
reflection of the resistance of the hyaluronate molecule to compression of its domain.
This is the effect of the repeating anionic charge along the chain, the stiffness of the
chain, its great length, and its tendency to extend throughout a large domain of
solution.
While the experiments on hindered sedimentation, excluded volume, and entangle-
ment with fibrils have all dealt with hyaluronate, they must be applied to other
connective tissue polysaccharides in the form as they exist in tissues, as compounds
with protein. The PP-L of cartilage also appears to be a diffuse molecule, though
not so diffuse as hyaluronate, because it is multiply branched. It gives solutions of
considerable viscosity, though not so viscous as hyaluronate. A major difference from
hyaluronate is that the viscosity of solutions of PP-L is destroyed in a few minutes
by treatment with trypsin.
There are several areas in which the concept of the entanglement of diffuse soluble
molecules with each other or with insoluble fibrils may help in handling connective
tissues in the laboratory or in explaining their properties in the animal. The dif-
ficulty usually found in extracting the native compounds of protein and polysac-
charide from connective tissue is particularly obvious in cartilage because there is
so much in this tissue. If this were due to entanglement of PP-L with the fine fibrils
of cartilage, one could understand why destruction of the fibrillar network yields
PP-L in solution in large amounts. There is even some difficulty in separating PP-L
from PP-H since several high speed centrifugings seem needed to effect good separa-
tion, though once separated PP-H sediments much more easily even at lower cen-
trifugal speeds.
Two further properties of some connective tissues that may be related to en-
tanglement of diffuse water-soluble molecules with fine insoluble fibrils are the bind-
ing of water in tissues and the elasticity of cartilage. The basis on which these proper-
ties are dependent is most clearly suggested in the experiments of Fessler described
above in which collagen fibrils freshly precipitated in hyaluronate solution and then
sedimented yielded elastic pellets with high water content.
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